publication venue for
- In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy.. e0122223. 2024
- Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates.. 67:e0013223-e00123. 2023
- Deletion of Rv2571c confers resistance to arylamide compounds in Mycobacterium tuberculosis.. 65:e02334-e02320. 2023
- Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant Mycobacterium tuberculosis.. 65:e02554-e02520. 2023
- Emergence of two AcrB substitutions conferring multidrug resistance to Salmonella spp.. 65:AAC.01589-AAC.01520. 2023
- Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections.. 67:e0003723-e00023. 2023
- Correction for Shelton et al., "Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis".. 66:e0096222-e00922. 2022
- Antimicrobial Resistance Hidden within Multiserovar Salmonella Populations.. 65:e00048-e00021. 2021
- Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis.. 65:e01948-e01920. 2020
- Chromosomal Resistance to Metronidazole in Clostridioides difficile Can Be Mediated by Epistasis between Iron Homeostasis and Oxidoreductases.. 64:e00415-e00420. 2020
- Novel Antiparasitic Activity of the Antifungal Lead Occidiofungin.. 64:e00244-e00220. 2020
- Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosis.. 63:e01006-e01019. 2019
- 3-O-Methyl-Alkylgallates Inhibit Fatty Acid Desaturation in Mycobacterium tuberculosis.. 63:e00136-e00119. 2019
- Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.. 62:e01574-e01517. 2018
- Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.. 61:e01334-e01317. 2017
- Susceptibility of Mycobacterium tuberculosis Cytochrome bd Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome c.. 61:e01338-e01317. 2017
- A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis In Vitro.. 61:e01205-e01217. 2017
- Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.. 60:6271-6280. 2016
- Rifamycin Resistance in Clostridium difficile Is Generally Associated with a Low Fitness Burden.. 60:5604-5607. 2016
- Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.. 60:4590-4599. 2016
- Extended-Spectrum-Cephalosporin Resistance Genes in Escherichia coli from Beef Cattle.. 60:1162-1163. 2016
- Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole.. 59:6113-6116. 2015
- Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.. 59:5494-5502. 2015
- Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.. 59:4199-4205. 2015
- A novel antimycobacterial compound acts as an intracellular iron chelator.. 59:2256-2264. 2015
- Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.. 58:687-697. 2014
- Caprine abscess model of tulathromycin concentrations in interstitial fluid from tissue chambers inoculated with Corynebacterium pseudotuberculosis following subcutaneous or intrachamber administration.. 57:6295-6304. 2013
- Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.. 57:2571-2581. 2013
- Both fidaxomicin and vancomycin inhibit outgrowth of Clostridium difficile spores.. 57:664-667. 2013
- The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.. 56:3758-3766. 2012
- Sublimable C5A delivery provides sustained and prolonged anti-HIV microbicidal activities.. 56:3336-3343. 2012
- MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.. 56:324-331. 2012
- Novel inhibitors of InhA efficiently kill Mycobacterium tuberculosis under aerobic and anaerobic conditions.. 55:3889-3898. 2011
- Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time.. 55:3272-3277. 2011
- Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis.. 55:3058-3062. 2011
- Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine.. 55:291-301. 2011
- Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.. 54:3776-3782. 2010
- Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles.. 54:388-396. 2010
- Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections.. 53:4028-4031. 2009
- In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.. 53:3285-3293. 2009
- Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.. 50:2762-2771. 2006
- Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.. 49:4821-4833. 2005
- Vancomycin-resistant Enterococcus faecium strains isolated from community wastewater from a semiclosed agri-food system in Texas.. 49:4382-4385. 2005
- Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.. 49:708-720. 2005
- Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.. 48:4366-4376. 2004
- Inhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections.. 47:2051-2055. 2003
- Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth.. 46:47-54. 2002
- Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells.. 36:982-988. 1992
- Reduced parasitemia observed with erythrocytes containing inositol hexaphosphate.. 32:391-394. 1988
- Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile. 2015